NDUFS4 and Leigh syndrome: Hence, we provide insight on the specific proteomic changes driven by NDUFS4 deficiency, which may underlie the molecular and metabolic alterations elicited by mitochondrial dysfunction, with the overarching goal of identifying novel molecular targets with therapeutic potential for LS and MD.